Scott Boilen is Director of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 37,345 shares of CKPT, which is worth approximately $140,043. The most recent transaction as insider was on Jun 13, 2023, when has been sold 17,483 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.3K
0% 3M change
0% 12M change
Total Value Held $140,043

Scott Boilen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2023
BUY
Grant, award, or other acquisition
-
17,483 Added 31.89%
37,345 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
47,619 Added 19.34%
198,621 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
16,502 Added 9.85%
151,004 Common Stock
SB

Scott Boilen

Director
New York, NY

Track Institutional and Insider Activities on CKPT

Follow Checkpoint Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CKPT shares.

Notify only if

Insider Trading

Get notified when an Checkpoint Therapeutics, Inc. insider buys or sells CKPT shares.

Notify only if

News

Receive news related to Checkpoint Therapeutics, Inc.

Track Activities on CKPT